Download Programme
Time Stage 1 Stage 2 Stage 3
0730 – 0845 Registration
0845 – 0915 Opening Ceremony
Guest-Of-Honour
Dr Janil Puthucheary
Senior Minister of State, Ministry of Communication and Information & Ministry of Health
0915 – 0945
Chair: Prof Dale Fisher, Singapore
Keynote / Plenary 1: COVID-19
Prof Cao Bin, China
0945 – 1015
Chair: Dr Mark Chen, Singapore
Keynote / Plenary 2: Advances in Influenza Therapeutics
Prof Frederick Hayden, United States of America
1015 – 1045 Coffee/Tea break / Exhibition / E-Posters viewing
1045 – 1245 Concurrent Symposia 1
ISAC Symposium
Chairs: Dr Catherine Ong, Singapore
Dr James Sim Heng Chiak, Singapore
Concurrent Symposia 2
Hot Topics in Microbiology
Chairs: Dr Jasmin Chung, Singapore
Dr Chew Ka Lip, Singapore
Concurrent Symposia 3
MERS CoV, Avian Influenza and Other Respiratory Viruses
Chair: Prof Gavin Smith, Singapore
1045 – 1115 From Answers in Days to Answers in Minutes
Prof Robin Patel, United States of America
Utility of Typing Carbapenemases
Prof David Paterson, Australia
Emerging Adenovirus Threats: Vaccine and Antiviral Interventions
Prof Gregory Gray, United States of America
1115 – 1145 Rapid Diagnosis for Bacterial Resistance
Prof Yohei Doi, Japan
Advances in Laboratory Mycology
Prof Arunaloke Chakrabarti, India
Novel Influenza Viruses
Prof Kanta Subbarao, Australia
1145 – 1215 Rapid Diagnosis: Where Engineering meets Infectious Diseases
Prof Jackie Y. Ying, Singapore
Clinical Virology: from Culture to Metagenomics
Prof Malik Peiris, Hong Kong SAR
Community MERS CoV: Clinical Aspects and Diagnosis
Prof Ziad Memish, Saudi Arabia
1215 – 1245 RABBIT: Randomised Trial of Rapid Diagnosis in Bacteraemia
Dr Shawn Vasoo, Singapore
The link between Clinical Microbiology and IPC
Prof Andreas Voss, Netherlands
Nosocomial MERS CoV and Hospital Response
Prof Doo Ryeon Chung, Republic of Korea
1245 – 1315 Lunch Break
1315 – 1415
Chair: Dr Hoe Nam Leong, Singapore
Effective management of cSSTI – bringing the focus back to the patient
Prof Murat Akova, Turkey
Dr Chia-Ying Liu, Taiwan

Chair: Dr Jasmin Chung, Singapore
Immunosenescence and the new recombinant zoster vaccine in the prevention of shingles
Dr Asok Kurup, Singapore

Chair: Dr James Sim Heng Chiak, Singapore
Current Trends in Superinfections in COVID 19 patients and Role of Microbiology – the Indian experience
Dr Aruna Poojary, India

1415 – 1615 Concurrent Symposia 4
Hot Topics in Infection Control
Chairs: A/Prof Brenda Ang, Singapore
Dr Surinder Pada, Singapore
Concurrent Symposia 5
One Health In Infectious Diseases
Chairs: A/Prof Ng Lee Ching, Singapore
Dr Lee Tau Hong, Singapore
Concurrent Symposia 6
Transplant Infectious Diseases
Chair: A/Prof Tan Thuan Tong, Singapore
Dr Ng Tong Yong, Singapore
1415 – 1445 WHO Infection Prevention and Control
Prof Wing Hong Seto, Hong Kong SAR
Why “One Health” is critical for Public Health
Prof Malik Peiris, Hong Kong SAR
Role of Prophylaxis in the Era of AMR
Prof Tan Ban Hock , Singapore
1445 – 1515 Myths in Infection Prevention and Control
Prof Anucha Apisarnthanarak, Thailand
One Health AMR And Human Health
A/Prof Direk Limmathurotsakul, Thailand
Antifungal Stewardship
Prof Monica Slavin, Australia
1515 – 1545 Evidence based MRSA Control
Prof Yee Chun Chen, Taiwan
One Health AMR in the Environment
A/Prof Karina Gin, Singapore
Parasitology in Transplantation
A/Prof Siriorn Watchanaranan, Thailand
1545 – 1615 Update in Sterilisation
A/Prof Ling Moi Lin, Singapore
Mitigating Future Pandemics: New Threats and Strategies to Consider
Prof Gregory Gray, United States of America
Viral Hepatitis In Transplantation
Prof Vincent Cheng, Hong Kong SAR
1615 – 1645
Chair: Prof Paul Tambyah, Singapore
Keynote / Plenary 3: Innovation in Antimicrobial Stewardship
Prof Alison Holmes, United Kingdom
1645 – 1715 Coffee/Tea break / Exhibition / E-Posters viewing
1715 – 1745
Chair: Prof Leo Yee Sin, Singapore
Keynote / Plenary 4: Bat Viruses and the Next Outbreak
Prof Linfa Wang, Singapore
1745 – 1915 Public Health Response on COVID
Chairs: A/Prof Angela Chow, Singapore
A/Prof Alex Cook, Singapore
Interactive Case-Based Panel Discussion on Managing CMV In The High-Risk Transplant Recipient
Chair: Dr Jasmine Chung, Singapore
Paediatric ID
Chairs: A/Prof Chong Chia Yin, Singapore
Dr Chan Si Min, Singapore
1745 – 1815 Public Health Response in Australia
Prof Paul Kelly, Australia
Introduction
Define the transplant recipient at high-risk of CMV infection and discuss the unmet needs and challenges in the management of CMV infection with patient cases
Prof Tan Ban Hock, Singapore
Syndromic Testing
Prof Cheng Hsun Chiu, Taiwan
1815 – 1845 Public Health Response in Taiwan
Dr Yi-Chun (Philip) Lo, Taiwan
1845 – 1915 Public Health Response in Singapore
A/Prof Vernon Lee, Singapore
Explore investigational CMV infection management options and emerging clinical data
Prof Joe Sasadeusz, Australia
Panel Discussion
Hand Food And Mouth Diseases
Dr Mong How Ooi, Malaysia
1915 – 2015
Chair: A/Prof Helen Oh, Singapore
The value of pneumococcal vaccination in adults with co-morbid conditions
Prof Charles Feldman, South Africa

2015 – 2200 Dinner
TIME Stage 1 Stage 2 Stage 3
0730 – 0815 Registration
0815 – 0915
Chair: Prof Yoshitomo Morinaga, Japan
Current states of ESBL (extended-spectrum β-lactamase) producing Enterobacterales infections and antimicrobial treatments
Prof Hiroshige Mikamo, Japan
Current status of ESBL – producing bacterial infections
Dr Katsunori Yanagihara, Japan
Options for the prevention and treatment of COVID-19
Chair : Dr Bruce Mungall, Singapore
Dr. Nakorn Premsri, Thailand
Dr Nan-Chang Chiu, Taiwan
Dr Erlina Burhan, Indonesia
Dr Barnaby Young, Singapore

The development and clinical validation of MIRXES Fortitude RT-CR test kit for COVID-19 pandemic In Singapore and Philippines
Chair: Adj. Assoc Professor Timothy Mark Sebastian Barkham, Singapore
Go! Developing Fortitude v2.1, an RT-PCR test for SARS-CoV-2’
Adj. Assoc Professor Timothy Mark Sebastian Barkham, Singapore
Challenges and Strategies for Conducting Clinical Validation of MiRXES Fortitude Kit 2.1 COVID-19 RT-PCR
Prof. Pia Marie S.. Albano, Philippines

0915 – 0945
Chair: A/Prof Koh Tse Hsien, Singapore
Keynote / Plenary 5: Assessing the Value of New Diagnostics
Prof Robin Patel, United States of America
0945 – 1015
Chair: Prof Benjamin Seet, Singapore
Keynote / Plenary 6: Using Covid-19 vaccines: Lessons from Control of Vaccine Preventable Diseases and the Eradication of Smallpox and Polio
Prof David Heymann, United Kingdom
1015 – 1045 Coffee/Tea break / Exhibition / E-Posters viewing
1045 – 1245 Concurrent Symposia 7
Clinical Implications of Microbiome
Chairs: A/Prof Gan Yunn Hwen, Singapore
Dr Barnaby Young, Singapore
Concurrent Symposia 8
Human Immunodeficiency Virus
Chairs: Dr Lin Li, Singapore
A/Prof Lee Cheng Chuan, Singapore
Concurrent Symposia 9
Mycology
Chairs: A/Prof Louis Chai, Singapore
Dr Zheng Shuwei, Singapore
1045 – 1115 Fungal Microbiome In Lung Diseases
Dr Sanjay Chotirmall, Singapore
Viral Hepatitis Co-Infections
Prof Sharon Lewin, Australia
New Risk Factors for Invasive Aspergillosis
Prof Monica Slavin, Australia
1115 – 1145 Implications of Environmental Microbiome
A/Prof Niranjan Nagarajan, Singapore
Pre-Exposure Prophylaxis HIV
Prof Andrew Grulich, Australia
Pre-Emptive Antifungal in Febrile Neutropenia
Prof Yee Chun Chen, Taiwan
1145 – 1215 Utility of Metagenomics in COVID-19 Disease
Prof Siew Chien Ng, Hong Kong SAR
New HAART
Prof Kiat Ruxrungtham, Thailand
Candida Auris
Prof Arunaloke Chakrabarthi, India
1215 – 1245 Next Generation Sequencing: First Diagnostic One-stop Shop in Clinical Microbiology
Prof John Rossen, Netherlands
HIV Decriminalisation
Prof Adeeba Kamarulzaman, Malaysia
Updates on Fungal Diagnostics
Dr Tan Yen Ee, Singapore
1245 – 1315 Lunch Break
1315 – 1415
Chair:Prof Yee Chun Chen, Taiwan
Evolutional and emerging issues for optimizing invasive mold infection management in Asia
Dr Samir Agrawal, UK
Prof Arunaloke Chakrabarti, India

Chair : Dr Asok Kurup, Singapore
Thinking Dengue Again – Chronicity, Antibiotics and Vaccination
Dr Andrew Green, Indonesia
Prof Nicole Huang, Taiwan
Dr Alberta Di Pasquale, Singapore

Chair: Dr. Helen Oh May Lin, Singapore
From patients to lab, back to patients: The Ronapreve story
Dr David Lye Chien Boon, Singapore

1415 – 1615 Concurrent Symposia 10
Hot Topics in Antimicrobial Stewardship
Chair: A/Prof Piotr Chlebicki, Singapore
Dr Jyoti Somani, Singapore
Concurrent Symposia 11
Malaria
Chair: A/Prof Kevin Tan, Singapore
Dr Limin Wijaya, Singapore
Concurrent Symposia 12
Vector Borne Infections
Chair: Dr Purnima Parthasarathy, Singapore
1415 – 1445 Implementation Barriers in Antimicrobial Stewardship in the USA
Dr Arjun Srinivasan, United States of America
Plasmodium Vivax
A/Prof Yeo Tsin Wen, Singapore
Ticks and emerging vector-borne diseases: In Singapore and beyond
Dr MacKenzie L. Kwak, Singapore
1445 – 1515 Antimicrobial Stewardship in Paediatrics
Prof Cheng-Hsun Chiu, Taiwan
Plasmodium Knowlesi
Dr Timothy William, Malaysia
Chikungunya and Zika
A/Prof Lisa Ng, Singapore
1515 – 1545 Does Antimicrobial Stewardship Work?
Prof Anucha Apisarnthanarak, Thailand
Immune Response and Malaria
Prof Laurent Renia, Singapore
Dengue
Prof Eng Eong Ooi, Singapore
1545 – 1615 Advancing the Integration Antimicrobial Stewardship and Infection Prevention
Prof Alison Holmes, United Kingdom
Drug Resistance and Malaria
Prof Nicholas Day, Thailand
Arboviruses in Asia
Dr Sherry Moi, Japan
1615 – 1700 Coffee/Tea break / Exhibition / E-Posters viewing
1700 – 1730
Chair: Dr Wong Sin Yew, Singapore
Keynote / Plenary 7: Infections in Immunocompromised Hosts
Prof Tan Ban Hock, Singapore
1730 – 1800
Chair: A/Prof Sophia Archuleta
Keynote / Plenary 8 HIV Cure: Are We Any Nearer?
Prof Sharon Lewin, Australia
1800 – 1900 Oral Presentation 1
Chairs: A/Prof David Allen, Singapore
Dr Jasmine Chung, Singapore
COVID Symposium: COVID 19 Treatment
Chairs: Prof Kim Sun Joo, Korea
Dr Tsang Tak Yin, Hong Kong SAR
Viral Hepatitis
Chair: TBA
United Kingdom Recovery
Prof Peter Horby, United Kingdom
Hepatitis B Cure
Prof Seng Gee Lim, Singapore
Treatment of Patients with COVID-19
Dr H. Clifford Lane, United States of America
Hepatitis C Elimination
Prof Margaret Hellard, Australia
TIME Stage 1 Stage 2 Stage 3
0730 – 0815 Registration
0815 – 0915 Oral Presentation 2
Chairs: TBA
COVID Symposium: Immune Response to COVID
Chairs: Prof Nicholas Gascoigne, Singapore
Management of Covid-19 in Japan
by Japanese Society for Chemotherapy

Chair: Prof Tetsuya Matsumoto
0815 – 0845 Understanding Infection and Immunity of SARS-CoV-2: from Diagnostics to Therapies
Prof Lisa Ng, Singapore
Control of 2020 coronavirus pandemic (Including Antigen Testing)
Dr Satoshi Takahashi, Japan
0845 – 0915 SARS-CoV-2 specific T cells: protection from infection or disease?
Prof Antonio Bertoletti, Singapore
Treatment for Covid-19 (Including Favipiravir)
Dr Hiroyuki Kunishima, Japan
0915 – 0945
Chair: Prof Paul Tambyah, Singapore
Keynote / Plenary 9: Global And Local Challenges in AMR
Prof Ramanan Laxminarayan, United States of America
1015 – 1030
Chair: A/Prof David Lye, Singapore
Keynote / Plenary 10: New Antibiotics
Prof David Paterson, Australia
1015 – 1045 Coffee/Tea break / Exhibition / E-Posters viewing
1045 – 1245 Concurrent Symposia 13
AMR in Human Health
Chairs: Dr Lee Tau Hong, Singapore
Dr Ooi Say Tat, Singapore
Concurrent Symposia 14
Tuberculosis and Mycobacteria
Chair: A/Prof Kevin Pethe, Singapore
Dr Purnima Parthasarathy, Singapore
Concurrent Symposia 15
Therapeutic Drug Monitoring / PK PD
Chairs: A/Prof Andrea Kwa, Singapore
A/Prof Christine Teng, Singapore
1045 – 1115 Treatment of XDR And PDR Gram Negative Bacteria
Prof Po Ren Hsueh, Taiwan
Corticosteroid in Tuberculosis
Prof Guy Thwaites, Vietnam
Optimising PK PD For Antimalarials
Prof Joel Tarning, Thailand
1115 – 1145 Control of XDR Acinetobacter Baumannii
Prof Vincent Cheng, Hong Kong SAR
Immunomodulation in Tuberculosis
Dr Catherine Ong, Singapore
TDM in Antifungals
Prof Deborah JE Marriott, Australia
1145 – 1215 Role of Surveillance in Combating AMR
Prof Jae Hoon Song, Republic of Korea
MDR TB in Singapore
A/Prof Cynthia Chee, Singapore
TDM in Beta-Lactams
Prof Jason Roberts, Australia
1215 – 1245 Epidemiology and Transmission of Carbapenem-Resistant Hypervirulent Klebsiella Pneumoniae
Prof Hui Wang, China
Non-Tuberculous Mycobacteria In Asia
Prof Po Ren Hsueh, Taiwan
TDM in Sepsis
Prof Jeffrey Lipman, AustraliaADDTR
1245 – 1315 Lunch Break
1315 – 1415
Chair: Prof Balaji Veeraraghavan, India
The glimpse of glistening solutions for MDRO infections in Asia
Prof Tobias Welte, Germany
Dr Asok Kurup, Singapore

Chair: Dr. Wong Chen Seong, Singapore
Inflammation in HIV: More Than Meets the Eyes
Dr. Sergio Serrano-Villar

Chair: Prof Glenda Gray, South Africa
Optimizing COVID-19 Vaccination in Asia Pacific
Prof Anna Ong-Lim, Philippines
Prof Young June Choe, Korea

1415 – 1615 Concurrent Symposia 16
Utility of Genomic Sequencing
Chairs: Prof Zamberi Sekawi, Malaysia
Dr Karrie Ko, Singapore
Concurrent Symposia 17
SARS COV2 in Singapore
Chairs: A/Prof Danny Soon, Singapore
Dr Louisa Sun, Singapore
Concurrent Symposia 18
Vaccines
Chairs: A/Prof Helen Oh, Singapore
A/Prof Chong Chia Yin, Singapore
1415 – 1445 Genomic Sequencing in Bacteria
Prof Yohei Doi, Japan
Role of National Centre in Emerging Infections
Prof Leo Yee Sin, Singapore
Novel Strategies Influenza Vaccination
Dr Barnaby Young, Singapore
1445 – 1515 Genomic Sequencing in MERS CoV
Dr Waleed Abdurhman Al-Jabr, Saudi Arabia
How SARS COV2 evolves
Dr Sebastian Maurer-Stroh, Singapore
Practical Considerations for COVID-19 Rollout Programs
A/Prof Lim Poh Lian, Singapore
1515 – 1545 Genomic Sequencing in Infection Control
Prof John Rossen, Netherlands
Infection Control in SARS COV2
Dr Kalisvar Marimuthu, Singapore
Rotavirus Vaccine Rollout
Prof Gagandeep Kang, India
1545 – 1615 Advances in Genomic Sequencing
A/Prof Niranjan Nagarajan, Singapore
COVID19 Diagnostics
Dr Shawn Vasoo, Singapore
Controversies in Vaccination
Prof Paul Tambyah, Singapore
1615 – 1645
Closing Ceremony
Presentation Of Awards:
1. Best Oral, 2. SIDS Institut Mérieux Young Investigator Award
1645 – 1715 Coffee/Tea break / Exhibition / E-Posters viewing

Note:
Programme is updated as of 2 November 2021
The programme may be subject to change without prior notice.
*Speaker pending confirmation